CIAM
CLPT icon

Caitong International Asset Management’s ClearPoint Neuro CLPT Stock Holding History

Caitong International Asset Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.3K Buy
+2,035
New +$25.4K 0.01% 797
2026
Q1 		– Sell
-38
Closed -$520 – 2670
2025
Q4 		$520 Buy
+38
New +$704 ﹤0.01% 1466

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Caitong International Asset Management's CLPT Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in ClearPoint Neuro (CLPT) in Q2 2026: 2,035 shares worth $36.3K. The stake represents 0.01% of the portfolio and ranks #797 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in CLPT as recently as Q4 2025.

Caitong International Asset Management first reported a position in CLPT in Q4 2025 and has held it in 2 quarters since. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Caitong International Asset Management held 2,035 shares of ClearPoint Neuro worth $36.3K as of Q2 2026.
  • ClearPoint Neuro was a new Caitong International Asset Management position in Q2 2026.
  • ClearPoint Neuro made up 0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #797 holding.
  • Caitong International Asset Management first reported a position in ClearPoint Neuro in Q4 2025 and has held it in 2 quarters since.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.